Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Show/Hide Filters
Staurosporine (HB0590)
Description:Potent, non-specific protein kinase inhibitor. Apoptosis inducer.
Purity:>98%
YC-1 (HB3521)
Description:Guanylyl cyclase activator. Also induces G1 cell cycle arrest.
Purity:>98%